扶正抗癌方联合吉非替尼治疗PS≤2分晚期NSCLC的疗效与安全性研究 / Study on the effect and safety of Fuzheng Kangai Decoction combined with gefitinib in the treatment of advanced NSCLC with PS ≤ 2
- Resource Type
- Academic Journal
- Source
- 现代中西医结合杂志 / Modern Journal of Integrated Traditional Chinese and Western Medicine. 23(3):229-250
- Subject
扶正抗癌方 吉非替尼 非小细胞肺癌 EGFR基因突变型 Fuzheng Kangai Decoction gefitinib non-small cell lung cancer epidermal growth factor receptor mutations - Language
- Chinese
- ISSN
- 1008-8849